{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:56:56Z","timestamp":1777499816793,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004937","name":"Federal Ministry of Education and Research Berlin Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jpsychores.2021.110385","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T17:02:06Z","timestamp":1612285326000},"page":"110385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Associations between NT-proBNP and psychosocial factors in patients with chronic systolic heart failure"],"prefix":"10.1016","volume":"143","author":[{"given":"Thomas","family":"M\u00fcller-Tasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Krug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Peters-Klimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jpsychores.2021.110385_bb0005","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpsychores.2017.01.010","article-title":"Depression increases the risk of mortality in patients with heart failure: a meta-analysis","volume":"94","author":"Gathright","year":"2017","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.jpsychores.2021.110385_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-015-9517-4","article-title":"Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis","volume":"21","author":"Sokoreli","year":"2016","journal-title":"Heart Fail. Rev."},{"issue":"10","key":"10.1016\/j.jpsychores.2021.110385_bb0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cardfail.2007.07.008","article-title":"Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice","volume":"13","author":"M\u00fcller-Tasch","year":"2007","journal-title":"J. Card. Fail."},{"issue":"4","key":"10.1016\/j.jpsychores.2021.110385_bb0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ejhf.55","article-title":"Disease-specific health status as a predictor of mortality in patients with heart failure: a systematic literature review and meta-analysis of prospective cohort studies","volume":"16","author":"Mastenbroek","year":"2014","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.jpsychores.2021.110385_bb0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/joim.12756","article-title":"Biomarkers for heart failure: small molecules with high clinical relevance","volume":"283","author":"Magnussen","year":"2018","journal-title":"J. Intern. Med."},{"issue":"22","key":"10.1016\/j.jpsychores.2021.110385_bb0035","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.jacc.2016.10.001","article-title":"NT-proBNP: the gold standard biomarker in heart failure","volume":"68","author":"McKie","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2014.00201","article-title":"Natriuretic hormones in brain function","volume":"5","author":"Hodes","year":"2014","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.jpsychores.2021.110385_bb0045","first-page":"5","article-title":"Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour","volume":"108","author":"Wiedemann","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"10.1016\/j.jpsychores.2021.110385_bb0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.PSY.0000073870.93003.C4","article-title":"High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure","volume":"65","author":"Herrmann-Lingen","year":"2003","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.jpsychores.2021.110385_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1253\/circj.CJ-08-0625","article-title":"Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure","volume":"73","author":"Tsuchihashi-Makaya","year":"2009","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.jpsychores.2021.110385_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/14017431.2012.658579","article-title":"Association between psychological measures and brain natriuretic peptide in heart failure patients","volume":"46","author":"Brouwers","year":"2012","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874192401307010054","article-title":"Relationship between cognitive function, depression\/anxiety and functional parameters in patients admitted for congestive heart failure","volume":"7","author":"Feola","year":"2013","journal-title":"Open Cardiovasc. Med. J."},{"issue":"9","key":"10.1016\/j.jpsychores.2021.110385_bb0075","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.amjcard.2009.01.025","article-title":"Relation of depression to severity of illness in heart failure (from heart failure and a controlled trial investigating outcomes of exercise training [HF-ACTION])","volume":"103","author":"Gottlieb","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1474515118772828","article-title":"Exploring potential biomarkers associated with health-related quality of life in patients with coronary artery disease and heart failure","volume":"17","author":"Kazukauskiene","year":"2018","journal-title":"Eur. J. Cardiovasc. Nurs."},{"issue":"5","key":"10.1016\/j.jpsychores.2021.110385_bb0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/08870446.2013.869813","article-title":"Depressive symptoms in outpatients with heart failure: importance of inflammatory biomarkers, disease severity and personality","volume":"29","author":"Brouwers","year":"2014","journal-title":"Psychol. Health"},{"issue":"5","key":"10.1016\/j.jpsychores.2021.110385_bb0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.amjcard.2010.10.055","article-title":"Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality","volume":"107","author":"van den Broek","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.jpsychores.2021.110385_bb0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurjhf\/hfp125","article-title":"Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study","volume":"11","author":"Parissis","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.jpsychores.2021.110385_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.2007.117390","article-title":"Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure","volume":"94","author":"Parissis","year":"2008","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.jpsychores.2021.110385_bb0105","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/eurjhf\/hfp155","article-title":"Depressive symptoms and outcomes in patients with heart failure: data from the COACH study","volume":"11","author":"Lesman-Leegte","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2018.06.010","article-title":"NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure","volume":"104","author":"Zuzarte","year":"2018","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychores.2021.110385_bb0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ahj.2011.01.003","article-title":"Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction","volume":"161","author":"Edelmann","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1745-6215-10-68","article-title":"Primary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial","volume":"10","author":"Peters-Klimm","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.jpsychores.2021.110385_bb0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1745-6215-11-56","article-title":"Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial","volume":"11","author":"Peters-Klimm","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.jpsychores.2021.110385_bb0130","first-page":"177","article-title":"Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki","volume":"5402","author":"Rickham","year":"1964","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jpsychores.2021.110385_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2009.06.061","article-title":"A network against failing hearts--introducing the German \u201cCompetence Network Heart Failure\u201d","volume":"145","author":"Mehrhof","year":"2010","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.jpsychores.2021.110385_bb0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0145","first-page":"131","article-title":"Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians\u00b4 diagnoses","author":"L\u00f6we","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0150","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"A.P. Association","year":"2000"},{"issue":"4","key":"10.1016\/j.jpsychores.2021.110385_bb0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","article-title":"The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review","volume":"32","author":"Kroenke","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychores.2021.110385_bb0160","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.jpsychores.2021.110385_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.jpsychores.2021.110385_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:QURE.0000018472.46236.05","article-title":"Health-related quality of life associated with chronic conditions in eight countries: results from the international quality of life assessment (IQOLA) project","volume":"13","author":"Alonso","year":"2004","journal-title":"Qual. Life Res."},{"issue":"6","key":"10.1016\/j.jpsychores.2021.110385_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"issue":"11","key":"10.1016\/j.jpsychores.2021.110385_bb0180","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11136-016-1316-4","article-title":"International SF-36 reference values in patients with ischemic heart disease","volume":"25","author":"Huber","year":"2016","journal-title":"Qual. Life Res."},{"issue":"8","key":"10.1016\/j.jpsychores.2021.110385_bb0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00392-017-1101-6","article-title":"Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial","volume":"106","author":"Chavanon","year":"2017","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.jpsychores.2021.110385_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity. a critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.jpsychores.2021.110385_bb0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7525-1-24","article-title":"A brief guide to the selection of quality of life instrument","volume":"1","author":"Hyland","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"issue":"4","key":"10.1016\/j.jpsychores.2021.110385_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00392-005-0205-6","article-title":"N-terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders","volume":"94","author":"Hess","year":"2005","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0210","doi-asserted-by":"crossref","first-page":"109728","DOI":"10.1016\/j.jpsychores.2019.05.006","article-title":"Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression","volume":"123","author":"Fangauf","year":"2019","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.jpsychores.2021.110385_bb0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000381218","article-title":"Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke","volume":"22","author":"Bunevicius","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.jpsychores.2021.110385_bb0230","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/s41598-017-15394-6","article-title":"Preoperative N-terminal pro-B-type natriuretic peptide concertation and prognosis of brain tumor patients: a 5-year follow up study","volume":"7","author":"Bunevicius","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jpsychores.2021.110385_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101746","article-title":"The endocrine function of the heart: physiology and involvements of natriuretic peptides and cyclic nucleotide phosphodiesterases in heart failure","volume":"8","author":"Lugnier","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.psyneuen.2018.06.001","article-title":"Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients","volume":"96","author":"Fangauf","year":"2018","journal-title":"Psychoneuroendocrinol"},{"issue":"2","key":"10.1016\/j.jpsychores.2021.110385_bb0245","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2012.01.062","article-title":"Incidence rates and predictors of major and minor depression in patients with heart failure","volume":"167","author":"Lossnitzer","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.jpsychores.2021.110385_bb0250","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpsychores.2012.09.019","article-title":"Time-course of depressive symptoms in patients with heart failure","volume":"74","author":"Johansson","year":"2013","journal-title":"J. Psychosom. Res."},{"issue":"1","key":"10.1016\/j.jpsychores.2021.110385_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardfail.2006.09.003","article-title":"The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients","volume":"13","author":"O\u2019Hanlon","year":"2007","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.jpsychores.2021.110385_bb0260","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cardfail.2019.07.546","article-title":"Is there an optimal time or method to obtain BNP levels?","volume":"25","author":"Ng","year":"2019","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.jpsychores.2021.110385_bb0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"Bandelow","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jpsychores.2021.110385_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2016.11.002","article-title":"The relationship between chronic physical conditions, multimorbidity and anxiety in the general population: a global perspective across 42 countries","volume":"45","author":"Vancampfort","year":"2017","journal-title":"Gen. Hosp. Psychiatry"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399921000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399921000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:46:29Z","timestamp":1758368789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399921000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":50,"alternative-id":["S0022399921000301"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110385","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between NT-proBNP and psychosocial factors in patients with chronic systolic heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110385"}}